Allogene Therapeutics Inc
(ALLO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,815 | 52,332 | 42,455 | 75,218 | 51,239 |
| Marketable Securities | 214,379 | 220,788 | 237,588 | 217,258 | 240,325 |
| TOTAL | $260,719 | $282,655 | $291,576 | $303,386 | $304,415 |
| Non-Current Assets | |||||
| PPE Net | 75,896 | 78,858 | 82,992 | 86,056 | 88,989 |
| Investments And Advances | 24,944 | 29,510 | 55,506 | 80,673 | 111,821 |
| Other Non-Current Assets | 78,212 | 79,570 | 77,908 | 78,595 | 83,895 |
| TOTAL | $179,052 | $187,938 | $216,406 | $245,324 | $284,705 |
| Total Assets | $439,771 | $470,593 | $507,982 | $548,710 | $589,120 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,699 | 4,851 | 5,058 | 5,394 | 5,506 |
| Accrued Expenses | 28,134 | 26,824 | 24,964 | 30,129 | 27,065 |
| TOTAL | $31,833 | $31,675 | $30,022 | $35,523 | $32,571 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 92,609 | 94,357 | 92,567 | 91,008 | 92,801 |
| TOTAL | $92,609 | $94,357 | $92,567 | $91,008 | $92,801 |
| Total Liabilities | $124,442 | $126,032 | $122,589 | $126,531 | $125,372 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 224,730 | 221,881 | 218,731 | 217,265 | 209,672 |
| Common Shares | 223 | 220 | 219 | 212 | 210 |
| Retained earnings | -1,971,899 | -1,930,499 | -1,879,556 | -1,819,823 | -1,759,884 |
| Other shareholders' equity | 235 | -45 | 43 | -89 | 157 |
| TOTAL | $315,329 | $344,561 | $385,393 | $422,179 | $463,748 |
| Total Liabilities And Equity | $439,771 | $470,593 | $507,982 | $548,710 | $589,120 |